61 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GRFS Grifols, S.A. $20.42 $13.96B Buy
Article Searches
Biotech Powerhouse CSL Down Over $50 Australian This Year https://seekingalpha.com/article/4229674-biotech-powerhouse-csl-50-australian-year?source=feed_sector_healthcare Dec 21, 2018 - Profit margins are north of 20%.CSL has a high moat is it is difficult to enter the plasma business.CSL is by far the largest plasma company in the world.
10 'Safer' Dividend Healthcare WallStars Gain 12-23% Per Broker October Targets And Dividends https://seekingalpha.com/article/4211834-10-safer-dividend-healthcare-wallstars-gain-12minus-23-percent-per-broker-october-targets?source=feed_all_articles Oct 16, 2018 - October's top net gain safer Healthcare WallStar is AbbVie. Its projected 23% net gain was 2.3% better than Sanofi's, and 3.4% more than Grifol's result per analyst targets of 10/12/18.WallStars all s
Healthcare 16-24% Target Net Gains Pace WallStars For October https://seekingalpha.com/article/4211623-healthcare-16minus-24-percent-target-net-gains-pace-wallstars-october?source=feed_all_articles Oct 15, 2018 - Big pharma drug makers and biotech continued to top the healthcare sector by broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare sector is comprised of 1
Is Grifols, S.A. (GRFS) a Great Stock for Value Investors? http://www.zacks.com/stock/news/323331/is-grifols-sa-grfs-a-great-stock-for-value-investors?cid=CS-ZC-FT-323331 Sep 17, 2018 - Is Grifols, S.A. (GRFS) a great pick from the value investor's perspective right now? Read on to know more.
36 'Safer' Dividend Healthcare WallStars For September https://seekingalpha.com/article/4205942-36-safer-dividend-healthcare-wallstars-september?source=feed_all_articles Sep 12, 2018 - Gilead took September's net gain safer Healthcare WallStar top spot. Its projected 21.82% net gain was 3% better than AbbVie's, and 29% more than Grifol's result, per analyst targets 9/10/18.WallStars
Aceto 72% Target Net Gain Tops WallStar Healthcare Equities For September https://seekingalpha.com/article/4205864-aceto-72-percent-target-net-gain-tops-wallstar-healthcare-equities-september?source=feed_all_articles Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
GRFS: Barclays starts at Overweight http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180601083059 Jun 01, 2018 - Barclays issues rating change for GRFS
Grifols S.A. goes ex-dividend tomorrow https://seekingalpha.com/news/3360791-grifols-s-goes-ex-dividend-tomorrow?source=feed_news_all May 31, 2018 - Grifols S.A. (NASDAQ:GRFS) had declared $0.250975/share semi-annual dividend.Payable June 5; for shareholders of record May 31; ex-div June 1.
'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisource, Anthem, And Johnson, Per Broker May Targets https://seekingalpha.com/article/4177005-safer-dividend-healthcare-top-wallstar-gainers-gilead-sanofi-amerisource-anthem-johnson-per?source=feed_all_articles May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
3Pea Is A Payment Processor With >40% Organic Growth Selling For Half Of Peer Multiples https://seekingalpha.com/article/4176361-3pea-payment-processor-40-percent-organic-growth-selling-half-peer-multiples?source=feed_tag_editors_picks May 22, 2018 - Payments processor serving the niche plasma donation market. Share winner in a growing industry with revenue potentially 4-8x higher in four years.Strong financial profile with high margins, ROIC, and

Pages: 1234567

Page 1>

Related Companies

Name Exchange Price Mkt Cap
BMRN BioMarin Pharmaceutical Inc. NASDAQ $98.11 $17.42B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
NKTR Nektar Therapeutics NASDAQ $58.29 $10.05B
PRGO Perrigo Company NYSE $72.57 $9.93B
JAZZ Jazz Pharmaceuticals plc NASDAQ $161.01 $9.73B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Grifols, S.A.
GRFS - Google Finance https://www.google.com/finance?q=GRFS Industry related info and international coverage Summary News
GRFS - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GRFS Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options